Atlas Trials

Study of JS004 Combined With Toripalimab for Advanced Lung Cancer

Clinical trial NCT05000684 · COMPLETED

Trial details

NCT number
NCT05000684
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Lung Cancer
Start date
2021-08-27
Primary completion
2024-10-31
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.